Home » Auxilium Pharmaceuticals Asks FDA to OK Xiaflex
Auxilium Pharmaceuticals Asks FDA to OK Xiaflex
Auxilium Pharmaceuticals filed a biologic license application with the Food and Drug Administration seeking marketing approval for Xiaflex, an experimental treatment for Dupuytren’s contracture.
Philadelphia Business Journal
Philadelphia Business Journal
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May